Clinical trials
Withdrawn Phase 2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NYU Langone Health | 2 |
| Cellectar Biosciences, Inc. | 1 |
| Constantinos Hadjipanayis | 1 |
| Dana-Farber Cancer Institute | 1 |
| Duke University | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| National Taiwan University Hospital | 1 |
| Pediatric Brain Tumor Consortium | 1 |
| Sophiris Bio Corp | 1 |
| University of Michigan Rogel Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 13 |
| Glioblastoma | 7 |
| Astrocytoma | 3 |
| Brain Neoplasms | 3 |
| Ependymoma | 3 |
| Oligodendroglioma | 3 |
| Central Nervous System Neoplasms | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Glioma, Subependymal | 1 |
| Gliosarcoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.